MSOX - 10% ADR but my nemesis ticker
I have a habit of tracking my total realized profits/loss in terms of 'R' for tickers I’ve traded repeatedly, and $AdvisorShares Pure US Cannabis ETF(MSOS)$ ranks among the worst.
My last 6 trades in MSOS was 2023 and 2024 to a 100% losing rate on 6 different occasion. MSOS have one of the highest beta in my ETF list but most of them move get faded aggressively in just a 3-4 days move, while I try to hold to the next day after a close below 10-MA, and breach LoD 30min at open.
Often than not, lots of profit will be evaporated even before T+3. Extremely important reminder that every single ticker in the market has its own characteristic in terms of price action development.
If not for the scar I've had with MSOS, i would have already took the trade on 30/6 first flag breakout, instead of this 2nd flag breakout. A lot of contemplation when you always think of 'nemsis' ticker before pulling the trigger.
T+2 already, will be executing partial 33% profit taking later at open, and can only hope for the best outcome for this to cover all my MSOS losses in the last 3 years.
Image
For whom haven't open CBA can know more from below:
🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!
Find out more here：
Trade on a Cash Boost Account and enjoy up to 6 months of Commission-Free trading.
💰Join the TB Contra Telegram Group to Get $10 Trading Vouchers Now🎉
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
